<VariationArchive VariationID="180647" VariationName="NM_005357.4(LIPE):c.1519_1520dup (p.Ser508fs)" VariationType="Duplication" Accession="VCV000180647" Version="3" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-03-11" DateCreated="2015-02-13" MostRecentSubmission="2024-03-10">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="178808" VariationID="180647">
      <GeneList>
        <Gene Symbol="LIPE" FullName="lipase E, hormone sensitive type" GeneID="3991" HGNC_ID="HGNC:6621" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>19q13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="42401514" stop="42427388" display_start="42401514" display_stop="42427388" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="42905665" stop="42931577" display_start="42905665" display_stop="42931577" Strand="-" />
          </Location>
          <OMIM>151750</OMIM>
        </Gene>
        <Gene Symbol="LIPE-AS1" FullName="LIPE antisense RNA 1" GeneID="100996307" HGNC_ID="HGNC:48589" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>19q13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="42397148" stop="42652355" display_start="42397148" display_stop="42652355" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC101930071" FullName="uncharacterized LOC101930071" GeneID="101930071" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>19q13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="42397128" stop="42408452" display_start="42397128" display_stop="42408452" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_005357.4(LIPE):c.1519_1520dup (p.Ser508fs)</Name>
      <CanonicalSPDI>NC_000019.10:42408111:GCG:GCGCG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>19q13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="42408111" stop="42408112" display_start="42408111" display_stop="42408112" variantLength="2" positionVCF="42408111" referenceAlleleVCF="G" alternateAlleleVCF="GGC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="42912263" stop="42912264" display_start="42912263" display_stop="42912264" variantLength="2" positionVCF="42912263" referenceAlleleVCF="G" alternateAlleleVCF="GGC" />
      </Location>
      <ProteinChange>S508fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.42408113_42408114dup" Assembly="GRCh38">
            <Expression>NC_000019.10:g.42408113_42408114dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.42912265_42912266dup" Assembly="GRCh37">
            <Expression>NC_000019.9:g.42912265_42912266dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_034246.1" sequenceAccession="NG_034246" sequenceVersion="1" change="g.24314_24315dup">
            <Expression>NG_034246.1:g.24314_24315dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005357.4" sequenceAccession="NM_005357" sequenceVersion="4" change="c.1519_1520dup" MANESelect="true">
            <Expression>NM_005357.4:c.1519_1520dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005348.2" sequenceAccession="NP_005348" sequenceVersion="2" change="p.Ser508fs">
            <Expression>NP_005348.2:p.Ser508fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="151750.0002" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff provided an HGVS expression for allelic variant 151750.0002 from the sequence reported in Figure 1E of the paper by Farhan et al., 2014 (PubMed 25475467).</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005357.4(LIPE):c.1519_1520dup (p.Ser508fs) AND LIPE-related familial partial lipodystrophy" Accession="RCV000157608" Version="9">
        <ClassifiedConditionList TraitSetID="19252">
          <ClassifiedCondition DB="MedGen" ID="C4014869">LIPE-related familial partial lipodystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2014-12-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2014-12-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2015-02-13" MostRecentSubmission="2024-03-10">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">24375490</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25475467</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="19252" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="31859" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">LIPE-related familial partial lipodystrophy</ElementValue>
                <XRef ID="MONDO:0014431" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH LIPE MUTATIONS</ElementValue>
                <XRef Type="MIM" ID="615980" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial partial lipodystrophy 6</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FPLD6</ElementValue>
                <XRef Type="MIM" ID="615980" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13126" />
                <XRef ID="13126" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="435660" DB="Orphanet" />
              <XRef ID="C4014869" DB="MedGen" />
              <XRef ID="MONDO:0014431" DB="MONDO" />
              <XRef Type="MIM" ID="615980" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="373024" SubmissionDate="2018-04-23" DateLastUpdated="2024-03-10" DateCreated="2015-02-13">
        <ClinVarSubmissionID localKey="151750.0002_LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6" title="LIPE, 2-BP INS, CG_LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6" />
        <ClinVarAccession Accession="SCV000207417" DateUpdated="2024-03-10" DateCreated="2015-02-13" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-12-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In an Italian sister and brother from a consanguineous family with familial partial lipodystrophy type 6 (FPLD6; 615980), originally reported by Carboni et al. (2014), Farhan et al. (2014) identified homozygosity for a 2-bp insertion in the LIPE gene. Farhan et al. (2014) referred to the mutation as an indel. The mutation caused a frameshift within the hormone-sensitive lipase domain predicted to result in a premature termination codon (Ala507fsTer563) with an approximately 50% loss of the original polypeptide. The mutation segregated with disease in the family and was not found in the NCBI dbSNP, 1000 Genomes Project, Human Gene Mutation, or Exome Variant Server databases, or in in-house control exomes. Both sibs had a late-onset form of partial lipodystrophy with elevated levels of creatine kinase. The sister exhibited mild proximal muscle weakness and dystrophic changes on muscle biopsy, whereas her brother had normal strength.</Attribute>
              <Citation>
                <ID Source="PubMed">24375490</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">25475467</ID>
              </Citation>
              <XRef DB="OMIM" ID="615980" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LIPE" />
          </GeneList>
          <Name>LIPE, 2-BP INS, CG</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP INS, CG</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="151750.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="373024" TraitType="Disease" MappingType="Name" MappingValue="LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6" MappingRef="Preferred">
        <MedGen CUI="C4014869" Name="LIPE-related familial partial lipodystrophy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

